NYSEAMERICAN:CVRS - Corindus Vascular Robotics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.7895 -0.01 (-1.25 %)
(As of 05/27/2018 01:31 PM ET)
Previous Close$0.7895
Today's Range$0.7602 - $0.8082
52-Week Range$0.66 - $2.25
Volume1.12 million shs
Average Volume903,038 shs
Market Capitalization$272.68 million
P/E RatioN/A
Dividend YieldN/A
Beta18.81

About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics logoCorindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. Its CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

Receive CVRS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVRS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:CVRS
CUSIPN/A
Phone+1-508-6533335

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-323.84%
Return on Equity-110.93%
Return on Assets-88.11%

Miscellaneous

EmployeesN/A
Outstanding Shares188,790,000

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Frequently Asked Questions

What is Corindus Vascular Robotics' stock symbol?

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."

How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) released its earnings results on Tuesday, May, 8th. The medical equipment provider reported ($0.08) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.05) by $0.03. The medical equipment provider had revenue of $1.49 million for the quarter, compared to analysts' expectations of $3.20 million. Corindus Vascular Robotics had a negative net margin of 323.84% and a negative return on equity of 110.93%. View Corindus Vascular Robotics' Earnings History.

What price target have analysts set for CVRS?

2 equities research analysts have issued 1 year price targets for Corindus Vascular Robotics' shares. Their forecasts range from $2.00 to $2.00. On average, they expect Corindus Vascular Robotics' share price to reach $2.00 in the next year. View Analyst Ratings for Corindus Vascular Robotics.

Are investors shorting Corindus Vascular Robotics?

Corindus Vascular Robotics saw a increase in short interest in the month of May. As of May 15th, there was short interest totalling 13,031,745 shares, an increase of 7.4% from the April 30th total of 12,138,919 shares. Based on an average daily trading volume, of 1,118,686 shares, the days-to-cover ratio is currently 11.6 days. Approximately 14.8% of the company's stock are short sold.

Who are some of Corindus Vascular Robotics' key competitors?

Who are Corindus Vascular Robotics' key executives?

Corindus Vascular Robotics' management team includes the folowing people:
  • Mr. Mark J. Toland, Pres, CEO & Director (Age 48)
  • Mr. David W. Long, CFO, Sr. VP, Sec. & Treasurer (Age 48)
  • Mr. Stephen Jeff Lemaster, Sr. VP & GM of Peripheral Intervention Segment (Age 47)
  • Mr. Tal Wenderow, Co-Founder and Exec. VP of International & Bus. Devel.
  • Mr. Doug Teany, Sr. VP of R&D and Operations

Has Corindus Vascular Robotics been receiving favorable news coverage?

Press coverage about CVRS stock has been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Corindus Vascular Robotics earned a media sentiment score of 0.10 on Accern's scale. They also assigned press coverage about the medical equipment provider an impact score of 47.61 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Corindus Vascular Robotics' major shareholders?

Corindus Vascular Robotics' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (1.30%), Migdal Insurance & Financial Holdings Ltd. (0.11%), Bronfman E.L. Rothschild L.P. (0.06%) and The Manufacturers Life Insurance Company (0.05%). Company insiders that own Corindus Vascular Robotics stock include Healthcor Management, LP, Jeffrey Gold, Louis A Cannon and Philips Nv Koninklijke. View Institutional Ownership Trends for Corindus Vascular Robotics.

Which institutional investors are buying Corindus Vascular Robotics stock?

CVRS stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Migdal Insurance & Financial Holdings Ltd., Bronfman E.L. Rothschild L.P. and The Manufacturers Life Insurance Company . Company insiders that have bought Corindus Vascular Robotics stock in the last two years include Healthcor Management, LP, Jeffrey Gold and Louis A Cannon. View Insider Buying and Selling for Corindus Vascular Robotics.

How do I buy shares of Corindus Vascular Robotics?

Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Corindus Vascular Robotics' stock price today?

One share of CVRS stock can currently be purchased for approximately $0.7895.

How big of a company is Corindus Vascular Robotics?

Corindus Vascular Robotics has a market capitalization of $272.68 million.

How can I contact Corindus Vascular Robotics?

Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.


MarketBeat Community Rating for Corindus Vascular Robotics (CVRS)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  237 (Vote Underperform)
Total Votes:  409
MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe CVRS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVRS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Corindus Vascular Robotics in the last 12 months. Their average twelve-month price target is $2.00, suggesting that the stock has a possible upside of 153.32%. The high price target for CVRS is $2.00 and the low price target for CVRS is $2.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.00$2.50$3.00$3.00
Price Target Upside: 153.32% upside82.48% upside80.72% upside80.72% upside

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Consensus Price Target History

Price Target History for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/21/2018Ladenburg ThalmannInitiated CoverageBuy$2.00View Rating Details
3/15/2018CowenSet Price TargetBuy$2.00View Rating Details
5/15/2017B. RileyReiterated RatingBuy$3.00View Rating Details
(Data available from 5/27/2016 forward)

Earnings

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Earnings History and Estimates Chart

Earnings by Quarter for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics (NYSEAMERICAN CVRS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018Q1($0.05)($0.08)$3.20 million$1.49 millionViewN/AView Earnings Details
3/14/2018Q4 2017($0.0350)($0.04)$3.90 million$4.19 millionViewListenView Earnings Details
11/7/2017Q3 2017($0.05)($0.04)$3.60 million$2.43 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.05)($0.04)$3.10 million$2.26 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.05)($0.07)$1.59 million$0.78 millionViewListenView Earnings Details
3/15/2017Q4 2016($0.07)($0.0820)$0.73 million$0.54 millionViewN/AView Earnings Details
11/8/2016Q316($0.06)($0.07)$1.27 million$0.69 millionViewListenView Earnings Details
8/4/2016Q2 2016($0.06)($0.06)$1.20 million$0.51 millionViewN/AView Earnings Details
5/5/2016Q1 2016($0.06)($0.06)$0.90 million$1.11 millionViewN/AView Earnings Details
3/8/2016Q415($0.05)($0.06)$0.62 million$0.83 millionViewN/AView Earnings Details
11/12/2015Q315($0.06)($0.06)$0.70 million$0.21 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Corindus Vascular Robotics (NYSEAMERICAN CVRS) Insider Trading and Institutional Ownership History

Insider Trading History for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)
Insider Trading History for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics (NYSEAMERICAN CVRS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2018Louis A CannonDirectorBuy16,500$0.79$13,035.00View SEC Filing  
5/16/2018Louis A CannonDirectorBuy6,000$0.81$4,860.00View SEC Filing  
11/13/2017Louis A CannonDirectorBuy23,801$0.81$19,278.81View SEC Filing  
3/22/2017Louis A CannonDirectorBuy27,000$1.30$35,100.00View SEC Filing  
2/28/2017Healthcor Management, L.P.Major ShareholderBuy7,557,436$0.66$4,987,907.76View SEC Filing  
11/25/2016Jeffrey GoldDirectorBuy10,000$0.76$7,600.009,098View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Corindus Vascular Robotics (NYSEAMERICAN CVRS) News Headlines

Source:
DateHeadline
Louis A. Cannon Acquires 16,500 Shares of Corindus Vascular Robotics (CVRS) StockLouis A. Cannon Acquires 16,500 Shares of Corindus Vascular Robotics (CVRS) Stock
www.americanbankingnews.com - May 25 at 10:10 PM
Corindus Vascular Robotics (CVRS) Sees Significant Growth in Short InterestCorindus Vascular Robotics (CVRS) Sees Significant Growth in Short Interest
www.americanbankingnews.com - May 24 at 5:28 PM
Corindus Vascular Robotics (CVRS) Now Covered by Ladenburg ThalmannCorindus Vascular Robotics (CVRS) Now Covered by Ladenburg Thalmann
www.americanbankingnews.com - May 21 at 11:02 AM
Corindus Vascular Robotics (CVRS) Upgraded by Zacks Investment Research to HoldCorindus Vascular Robotics (CVRS) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 16 at 9:24 PM
BRIEF-Corindus Vascular Robotics Files For Non-Timely 10-Q - SEC FilingBRIEF-Corindus Vascular Robotics Files For Non-Timely 10-Q - SEC Filing
www.reuters.com - May 12 at 10:19 AM
Corindus Vascular Robotics (CVRS) CEO Mark Toland on Q1 2018 Results - Earnings Call TranscriptCorindus Vascular Robotics' (CVRS) CEO Mark Toland on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 10:19 AM
Edited Transcript of CVRS earnings conference call or presentation 8-May-18 8:30pm GMTEdited Transcript of CVRS earnings conference call or presentation 8-May-18 8:30pm GMT
finance.yahoo.com - May 10 at 9:49 AM
Corindus Vascular Robotics (CVRS) Short Interest UpdateCorindus Vascular Robotics (CVRS) Short Interest Update
www.americanbankingnews.com - May 10 at 1:39 AM
Corindus Vascular Robotics (CVRS) Posts Quarterly  Earnings Results, Misses Estimates By $0.03 EPSCorindus Vascular Robotics (CVRS) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS
www.americanbankingnews.com - May 9 at 12:58 PM
Corindus Vascular: 1Q Earnings SnapshotCorindus Vascular: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 9:38 AM
Corindus Reports First Quarter 2018 ResultsCorindus Reports First Quarter 2018 Results
finance.yahoo.com - May 8 at 4:21 PM
Corindus Vascular Robotics (CVRS) Scheduled to Post Earnings on TuesdayCorindus Vascular Robotics (CVRS) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - May 2 at 8:47 PM
Corindus to Report First Quarter Financial Results on May 8, 2018Corindus to Report First Quarter Financial Results on May 8, 2018
finance.yahoo.com - April 27 at 4:22 PM
Corindus Vascular Robotics (CVRS) Sees Significant Decrease in Short InterestCorindus Vascular Robotics (CVRS) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - April 25 at 1:44 AM
Corindus Vascular Robotics (CVRS) Rating Lowered to Sell at ValuEngineCorindus Vascular Robotics (CVRS) Rating Lowered to Sell at ValuEngine
www.americanbankingnews.com - April 17 at 10:55 PM
Corindus Vascular Robotics (CVRS) Downgraded to "Hold" at BidaskClubCorindus Vascular Robotics (CVRS) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - April 16 at 8:40 PM
BRIEF-Corindus Vascular Robotics Offering, Resale By Selling Stockholders Of Up To 40.8 Mln Shares Of Common ...BRIEF-Corindus Vascular Robotics Offering, Resale By Selling Stockholders Of Up To 40.8 Mln Shares Of Common ...
www.reuters.com - April 13 at 4:22 PM
Corindus Vascular Robotics (CVRS) Lifted to Hold at BidaskClubCorindus Vascular Robotics (CVRS) Lifted to Hold at BidaskClub
www.americanbankingnews.com - April 11 at 3:58 PM
Corindus Vascular Robotics (CVRS) Given a $3.00 Price Target at CowenCorindus Vascular Robotics (CVRS) Given a $3.00 Price Target at Cowen
www.americanbankingnews.com - April 11 at 1:21 PM
Corindus Vascular Robotics (CVRS) Short Interest Down 5.2% in MarchCorindus Vascular Robotics (CVRS) Short Interest Down 5.2% in March
www.americanbankingnews.com - April 11 at 2:04 AM
Corindus Vascular Robotics (CVRS) Stock Rating Lowered by BidaskClubCorindus Vascular Robotics (CVRS) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 10 at 9:45 AM
Corindus Vascular Robotics (CVRS) Cut to "Hold" at Zacks Investment ResearchCorindus Vascular Robotics (CVRS) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 9 at 11:27 PM
Corindus Vascular Robotics (CVRS) Downgraded to "Sell" at ValuEngineCorindus Vascular Robotics (CVRS) Downgraded to "Sell" at ValuEngine
www.americanbankingnews.com - April 8 at 9:37 AM
Corindus Vascular Robotics (CVRS) Lowered to "Strong Sell" at BidaskClubCorindus Vascular Robotics (CVRS) Lowered to "Strong Sell" at BidaskClub
www.americanbankingnews.com - April 7 at 3:19 PM
Short Interest in Corindus Vascular Robotics Inc (CVRS) Declines By 0.1%Short Interest in Corindus Vascular Robotics Inc (CVRS) Declines By 0.1%
www.americanbankingnews.com - March 28 at 1:40 AM
Corindus Vascular Robotics (CVRS) Announces $25M Private Placement of Series A Convertible Preferred Shares, WarrantsCorindus Vascular Robotics (CVRS) Announces $25M Private Placement of Series A Convertible Preferred Shares, Warrants
www.streetinsider.com - March 16 at 5:17 PM
The Corindus Vascular Robotics Inc. Roller Coaster Hits Another Upswing. Here's WhyThe Corindus Vascular Robotics Inc. Roller Coaster Hits Another Upswing. Here's Why
finance.yahoo.com - March 16 at 5:17 PM
Corindus Vascular Robotics (CVRS) Presents At 38th Annual Cowen And Company Healthcare Conference - SlideshowCorindus Vascular Robotics (CVRS) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
seekingalpha.com - March 15 at 4:48 PM
Corindus Vascular Robotics (CVRS) Given a $2.00 Price Target at CowenCorindus Vascular Robotics (CVRS) Given a $2.00 Price Target at Cowen
www.americanbankingnews.com - March 15 at 3:44 PM
Corindus Vascular Robotics (CVRS) Releases Quarterly  Earnings Results, Hits EstimatesCorindus Vascular Robotics (CVRS) Releases Quarterly Earnings Results, Hits Estimates
www.americanbankingnews.com - March 15 at 1:20 PM
Corindus Vascular Robotics (CVRS) CEO Mark Toland on Q4 2017 Results - Earnings Call TranscriptCorindus Vascular Robotics' (CVRS) CEO Mark Toland on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - March 15 at 9:32 AM
Corindus Vascular Robotics EPS in-line, beats on revenueCorindus Vascular Robotics EPS in-line, beats on revenue
seekingalpha.com - March 14 at 5:32 PM
Heres Why Corindus Vascular Robotics Inc. Is Surging TodayHere's Why Corindus Vascular Robotics Inc. Is Surging Today
www.msn.com - March 14 at 5:32 PM
Here's Why Corindus Vascular Robotics Inc. Is Surging TodayHere's Why Corindus Vascular Robotics Inc. Is Surging Today
finance.yahoo.com - March 14 at 5:32 PM
Corindus Reports Fourth Quarter and Full Year 2017 ResultsCorindus Reports Fourth Quarter and Full Year 2017 Results
finance.yahoo.com - March 14 at 5:32 PM
Corindus Vascular Robotics (CVRS) Appoints James Tobin to Board - StreetInsider.comCorindus Vascular Robotics (CVRS) Appoints James Tobin to Board - StreetInsider.com
www.streetinsider.com - March 13 at 6:12 PM
Corindus to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018Corindus to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018
finance.yahoo.com - March 13 at 6:12 PM
James R. Tobin Joins Corindus Board of DirectorsJames R. Tobin Joins Corindus Board of Directors
finance.yahoo.com - March 13 at 9:56 AM
Corindus to Present at Cowen Health Care ConferenceCorindus to Present at Cowen Health Care Conference
finance.yahoo.com - March 12 at 5:23 PM
Corindus Vascular Robotics Inc (CVRS) Short Interest UpdateCorindus Vascular Robotics Inc (CVRS) Short Interest Update
www.americanbankingnews.com - March 9 at 6:25 PM
Blog Exposure - FDA Approves First Automated Robotic Movement in technIQ(TM) Series for Corindus’ CorPath GRX PlatformBlog Exposure - FDA Approves First Automated Robotic Movement in technIQ(TM) Series for Corindus’ CorPath GRX Platform
finance.yahoo.com - March 7 at 9:44 AM
Corindus Receives FDA Clearance for First Automated Robotic Movement in technIQ™ Series for CorPath GRX PlatformCorindus Receives FDA Clearance for First Automated Robotic Movement in technIQ™ Series for CorPath GRX Platform
finance.yahoo.com - March 5 at 9:53 AM
Corindus Vascular Robotics Inc (CVRS) Sees Significant Increase in Short InterestCorindus Vascular Robotics Inc (CVRS) Sees Significant Increase in Short Interest
www.americanbankingnews.com - February 27 at 6:00 PM
Delray Beach Medical Center Performs First Robotic-Assisted Peripheral Vascular Intervention Using Corindus CorPath® GRX System Following FDA ClearanceDelray Beach Medical Center Performs First Robotic-Assisted Peripheral Vascular Intervention Using Corindus CorPath® GRX System Following FDA Clearance
finance.yahoo.com - February 22 at 9:24 AM
Corindus Vascular Robotics (CVRS) Reports FDA Clearance for CorPath GRX System in Peripheral Vascular InterventionsCorindus Vascular Robotics (CVRS) Reports FDA Clearance for CorPath GRX System in Peripheral Vascular Interventions
www.streetinsider.com - February 20 at 9:11 AM
Corindus Receives FDA Clearance for CorPath® GRX System in Peripheral Vascular InterventionsCorindus Receives FDA Clearance for CorPath® GRX System in Peripheral Vascular Interventions
finance.yahoo.com - February 20 at 9:11 AM
Free Research Reports on These Medical Equipment Stocks -- Corindus Vascular Robotics, Myomo, InspireMD, and MiMedxFree Research Reports on These Medical Equipment Stocks -- Corindus Vascular Robotics, Myomo, InspireMD, and MiMedx
www.bizjournals.com - January 31 at 9:16 AM
Corindus Vascular Robotics (CVRS) Rating Lowered to Sell at Zacks Investment ResearchCorindus Vascular Robotics (CVRS) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - January 29 at 10:10 PM
Corindus Vascular Robotics Inc (CVRS) Sees Significant Growth in Short InterestCorindus Vascular Robotics Inc (CVRS) Sees Significant Growth in Short Interest
www.americanbankingnews.com - January 24 at 6:08 PM
Corindus Vascular Robotics (CVRS) Sees Q4 Revenue of $4-$4.2MCorindus Vascular Robotics (CVRS) Sees Q4 Revenue of $4-$4.2M
www.streetinsider.com - January 24 at 9:27 AM

SEC Filings

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Corindus Vascular Robotics (NYSEAMERICAN CVRS) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.